RARA CRAFT DATABASE for FDA Medical Devices
510(k)K232736

FDA DEVICE FACTS

Chemtrue® Drug Screen Fentanyl/Tramadol Cup Test, Chemtrue® Drug Screen Fentanyl/Tramadol Dip Card Test, Chemtrue® Multi-Panel Drug Screen Cup Test, Chemtrue® Multi-Panel Drug Screen Dip Card Test

Chemtron Biotech, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEDecember 20, 2023PRODUCT CODEDJG

Indications for use

The Chemtrue® Drug Screen Fentanyl / Tramadol Dip Card Test is a rapid lateral flow immunoassay for the qualitative detection of Norfentanyl (FYL) 5 and Tramadol (TML) 100 drugs in human urine. It is an in vitro diagnostic device. The test cut-off concentrations and calibrators are listed below: Analyte Abbreviation Calibrator Cutoff Concentration (ng/mL) Norfentanyl FYL Norfentanyl 5 Tramadol TML Tramadol 100 The Chemtrue® Drug Screen Fentanyl / Tramadol Dip Card Test detects and is calibrated against norfentanyl, the major metabolite of fentanyl in human urine. The test is available in Single and multi-panels. The test provides only a preliminary result. A more specific alternative chemical method must be used in order to obtain a confirmed assay result. Gas Chromatography / Mass Spectrometry (GC/MS) or Liquid Chromatography / Mass Spectrometry (LC/MS) are the preferred confirmatory methods. Clinical consideration and professional judgment should be applied to the drug test result, particularly when preliminary positive result is indicated. The test is not intended to differentiate between drugs of abuse and prescription use of Fentanyl/ Tramadol. The test is for in vitro diagnostic use only. The Chemtrue® Drug Screen Fentanyl / Tramadol Cup Test is a rapid lateral flow immunoassay for the qualitative detection of Norfentanyl (FYL) 5 and Tramadol (TML) 100 drugs in human urine. It is an in vitro diagnostic device. The test cut-off concentrations and calibrators are listed below: Analyte Abbreviation Calibrator Cutoff Concentration (ng/mL) Norfentanyl FYL Norfentanyl 5 Tramadol TML Tramadol 100 The Chemtrue® Drug Screen Fentanyl / Tramadol Cup Test detects and is calibrated against norfentanyl, the major metabolite of fentanyl in human urine. The test is available in Single and multi-panels. The test provides only a preliminary result. A more specific alternative chemical method must be used in order to obtain a confirmed assay result. Gas Chromatography / Mass Spectrometry (GC/MS) or Liquid Chromatography / Mass Spectrometry (LC/MS) are the preferred confirmatory methods. Clinical consideration and professional judgment should be applied to the drug test result, particularly when preliminary positive result is indicated. The test is not intended to differentiate between drugs of abuse and prescription use of Fentanyl/ Tramadol. The test is for in vitro diagnostic use only. The Chemtrue® Multi-Panel Drug Screen Dip Card Test is a rapid lateral flow immunoassay for the qualitative detection of Amphetamine, Barbiturates, Benzodiazepines, Buprenorphine, Cocaine, Ecstasy, Norfentanyl, Marijuana, Methamphetamine, Methadone, Morphine, Opiates, Oxycodone, Phencyclidine, Propoxyphene, Tramadol and Tricyclic Antidepressants (TCA) drugs in human urine. The test cut-off concentrations and the compounds the tests are calibrated to are as follows: Analyte Abbreviation Calibrator Cutoff Concentration (ng/mL) Amphetamine AMP d-Amphetamine 300 Amphetamine AMP d-Amphetamine 500 Amphetamine AMP d-Amphetamine 1,000 Barbiturates BAR Secobarbital/Pentobarbital 200 Barbiturates BAR Secobarbital/Pentobarbital 300 Benzodiazepines BZO Oxazepam 200 Benzodiazepines BZO Oxazepam 300 Buprenorphine BUP Buprenorphine 10 Cocaine COC Benzoylecgonine 150 Cocaine COC Benzoylecgonine 300 Ecstasy MDMA d,l-Methylenedioxy methamphetamine 500 Norfentanyl FYL Norfentanyl 5 Methamphetamine MET d-Methamphetamine 300 Methamphetamine MET d-Methamphetamine 500 Methamphetamine MET d-Methamphetamine 1,000 Marijuana THC 11-nor-Δ9-THC-9-COOH 50 Methadone MTD Methadone 300 Morphine MOR Morphine 300 Opiates OPI Morphine 2,000 Oxycodone OXY Oxycodone 100 Phencyclidine PCP Phencyclidine 25 Propoxyphene PPX Propoxyphene 300 Tricyclic Antidepressants TCA Nortriptyline 1,000 Tramadol TML Tramadol 100 The multi test panels can consist of any drug analytes listed above in any combination. Only one cut-off concentration will be included per analyte per device. The test provides only a preliminary result. A more specific alternative chemical method must be used in order to obtain a confirmed assay result. Gas Chromatography / Mass Spectrometry (GC/MS) or Liquid Chromatography / Mass Spectrometry (LC/MS) are the preferred confirmatory methods. Clinical consideration and professional judgment should be applied to any drugs of abuse test result, particularly when preliminary positive results are indicated. The tests are not intended to differentiate between drugs of abuse and prescription use of Benzodiazepines, Barbiturates, Buprenorphine, Oxycodone, Propoxyphene and Tricyclic Antidepressants. The Chemtrue® Multi-Panel Drug Screen Cup Test is a rapid lateral flow immunoassay for the qualitative detection of Amphetamine, Barbiturates, Benzodiazepines, Buprenorphine, Cocaine, Ecstasy, Norfentanyl, Marijuana, Methamphetamine, Methadone, Morphine, Opiates, Oxycodone, Phencyclidine, Propoxyphene, Tramadol and Tricyclic Antidepressants (TCA) drugs in human urine. The test cut-off concentrations and the compounds the tests are calibrated to are as follows: Analyte Abbreviation Calibrator Cutoff Concentration (ng/mL) Amphetamine AMP d-Amphetamine 300 Amphetamine AMP d-Amphetamine 500 Amphetamine AMP d-Amphetamine 1,000 Barbiturates BAR Secobarbital/Pentobarbital 200 Barbiturates BAR Secobarbital/Pentobarbital 300 Benzodiazepines BZO Oxazepam 200 Benzodiazepines BZO Oxazepam 300 Buprenorphine BUP Buprenorphine 10 Cocaine COC Benzoylecgonine 150 Cocaine COC Benzoylecgonine 300 Ecstasy MDMA d,l-Methylenedioxy methamphetamine 500 Norfentanyl FYL Norfentanyl 5 Methamphetamine MET d-Methamphetamine 300 Methamphetamine MET d-Methamphetamine 500 Methamphetamine MET d-Methamphetamine 1,000 Marijuana THC 11-nor-Δ9-THC-9-COOH 50 Methadone MTD Methadone 300 Morphine MOR Morphine 300 Opiates OPI Morphine 2,000 Oxycodone OXY Oxycodone 100 Phencyclidine PCP Phencyclidine 25 Propoxyphene PPX Propoxyphene 300 Tricyclic Antidepressants TCA Nortriptyline 1,000 Tramadol TML Tramadol 100 The multi test panels can consist of any drug analytes listed above in any combination. Only one cut-off concentration will be included per analyte per device. The test provides only a preliminary result. A more specific alternative chemical method must be used in order to obtain a confirmed assay result. Gas Chromatography / Mass Spectrometry (GC/MS) or Liquid Chromatography / Mass Spectrometry (LC/MS) are the preferred confirmatory methods. Clinical consideration and professional judgment should be applied to any drugs of abuse test result, particularly when preliminary positive results are indicated. The tests are not intended to differentiate between drugs of abuse and prescription use of Benzodiazepines, Barbiturates, Buprenorphine, Oxycodone, Propoxyphene and Tricyclic Antidepressants.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 17, 2026